Search Results 581-590 of 16824 for GLP-1 agonists

  1. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    In two placebo-controlled induction trials — OCTAVE Induction 1 and 2 — tofacitinib outperformed placebo in achieving remission in patients with UC.

  2. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  3. Digestive Diseases Clinical Trials - Medical Professionals

    One uncontrolled, unpublished study suggests that a footstool improved bowel ... 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) who are ...

  4. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

    About this study. To evaluate the effectiveness of NY-ESO-1-Specific (c259) T Cells, alone or in combination with other anti-cancer agents, in HLA-A*02:01, ...

  5. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) - Mayo Clinic

    The purpose of this study is to look at the effectiveness of giving participants who have been diagnosed with ET or PV one of two different study regimens over ...

  6. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... Women of childbearing potential (WOCBP), beginning at menarche, must agree to the ...

  7. Myocarditis - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the ... Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri ...

  8. A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer - Mayo Clinic

    Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of cancer ...

  9. Phase ll Study of Pirfenidone in Patients With RAILD - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after ... 1 FVC – Visit 2 FVC) / Visit 1 FVC];; percent predicted DLCO or TLCO ≥ 25 ...

  10. Neurology - Clinical trials - Mayo Clinic

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...